Long-Term Treatment with Buprenorphine/Naloxone in Primary Care: Results at 2–5 Years

REFERENCES

• Fiellin D A, O'Connor P G. New federal initiatives to enhance the medical treatment of opioid dependence. Ann Intern Med. 2002; 137: 688–692
   PubMed Web of Science ®Google Scholar
• Preventing HIV Infection among Injecting Drug Users in High Risk Countries. National Academies Press, Washington, DC 2006
   Google Scholar
• Hubbard R L, Craddock S G, Anderson J. Overview of five-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003; 25: 125–134
   PubMed Web of Science ®Google Scholar
• D'Ippoliti D, Davoli M, Perucci C A, Pasqualini F, Bargagli A M. Retention in treatment of heroin users in Italy: The role of treatment type and of methadone maintenance dosage. Drug Alcohol Depend. 1998; 52: 167–171
   PubMed Web of Science ®Google Scholar
• Ball J C, Ross A. The Effectiveness of Methadone Maintenance Treatment. Springer-Verlag Inc, New York 1991
   Google Scholar
• Gossop M, Mardsen J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2001; 62: 255–264
   PubMed Web of Science ®Google Scholar
• Fiellin D A, Pantalon M V, Chawarski M C, et al. Counseling plus buprenorphine-naloxone therapy for opioid dependence. N Eng J Med. 2006; 355: 365–374
   PubMed Web of Science ®Google Scholar
• Fudala P J, Bridge T P, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003; 349: 949–958
   PubMed Web of Science ®Google Scholar
• Cozzolino E, Guglielmino L, Vigezzi P, et al. Buprenorphine treatment: A three-year prospective study in opioid-addicted patients of a public out-patient addiction center in Milan. Am J Addict. 2006; 15: 246–251
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Fiellin D A, Pantalon M V, Pakes J P, O'Connor P G, Chawarski M C, Schottenfeld R C. Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse. 2002; 28: 231–241
   PubMed Web of Science ®Google Scholar
• O'Connor P G, Oliveto A H, Shi J M, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998; 105: 100–105
   PubMed Web of Science ®Google Scholar
• Pantalon M V, Fiellin D A, O'Connor P G, Chawarski M, Pakes J, Schottenfeld R S. Counseling requirements for buprenorphine maintenance in primary care: Lessons learned from a preliminary study in a methadone maintenance program. Addictive Disorders and Their Treatment. 2004; 3: 71–76
   Google Scholar
• Fiellin D A, O'Connor P G, Chawarski M, Pakes J P, Pantalon M V, Schottenfeld R S. Methadone maintenance in primary care: A randomized controlled trial. JAMA. 2001; 286: 1724–1731
   PubMed Web of Science ®Google Scholar
• Barry D T, Moore B A, Pantalon M V, et al. Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med. 2007; 22: 242–245
   PubMed Web of Science ®Google Scholar
• Petry N M, Bickel W K, Piasecki D, Marsch L A, Badger G J. Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine. Am J Addict. 2000; 9: 265–269
   PubMed Web of Science ®Google Scholar
• Herve S, Riachi G, Noblet C, et al. Acute hepatitis due to buprenorphine administration. Eur J Gastroenterol Hepatol. 2004; 16: 1033–1037
   PubMed Web of Science ®Google Scholar
• Schwartz R P, Brooner R K, Montoya I D, Currens M, Hayes M. A 12-year follow-up of a methadone medical maintenance program. Am J Addict. 1999; 8: 293–299
   PubMed Web of Science ®Google Scholar
• Salsitz E A, Joseph H, Frank B, et al. Methadone medical maintenance (MMM): Treating chronic opioid dependence in private medical practice—a summary report (1983–1998). The Mount Sinai Journal of Medicine. 2000; 67: 388–397
   PubMed Web of Science ®Google Scholar
• Caplehorn J R, Bell J. Methadone dosage and retention of patients in maintenance treatment. Med J Aust. 1991; 154: 195–199
   PubMed Web of Science ®Google Scholar
• Strain E C, Bigelow G E, Liebson I A, Stitzer M L. Moderate- vs. high-dose methadone in the treatment of opioid dependence. A randomized trial. JAMA. 1999; 281: 1000–1005
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Liebson I A, Bigelow G E. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med. 1993; 119: 23–37
   PubMed Web of Science ®Google Scholar
• Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2007; 3
   Google Scholar
• Kissin W, McLeod C, Sonnefeld J, Stanton A. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. J Addict Dis. 2006; 25: 91–103
   PubMed Web of Science ®Google Scholar
• Sullivan L E, Chawarski M, O'Connor P G, Schottenfeld R S, Fiellin D A. The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?. Drug Alcohol Depend 2005; 79: 113–116
   PubMed Web of Science ®Google Scholar
• Ling W, Charuvastra C, Collins J F, et al. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction. 1998; 93: 475–486
   PubMed Web of Science ®Google Scholar
• Ling W, Wesson D R, Charuvastra C, Klett C J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996; 53: 401–407
   PubMed Web of Science ®Google Scholar
• Kosten T R, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993; 181: 358–364
   PubMed Web of Science ®Google Scholar
• Stein M D, Cioe P, Friedmann P D. Buprenorphine retention in primary care. J Gen Intern Med. 2005; 20: 1038–1041
   PubMed Web of Science ®Google Scholar
• Hser Y, Hoffman V, Grella C, Anglin M. A 33-year follow-up of narcotic addicts. Arch Gen Psychiatry. 2001; 58: 503–508
   PubMed Web of Science ®Google Scholar
• McLellan A T, Lewis D C, O'Brien C P, Kleber H D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA. 2000; 284: 1689–1695
   PubMed Web of Science ®Google Scholar